| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 91,210 | 82,434 | 73,665 | 85,457 | | Cost of Revenue | 78,200 | 72,431 | 68,320 | 84,891 | | | Gross Profit | 13,010 | 10,003 | 5,345 | 566 | | | Operating Expenses | | Research Development | 2,108 | 1,799 | 1,878 | 1,889 | | Selling General and Administrative | 11,457 | 10,111 | 9,242 | 11,417 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (555) | (1,907) | (5,775) | (12,740) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 23 | 208 | (174) | (765) | | Earnings Before Interest And Taxes | (9,441) | (1,699) | (5,949) | (13,505) | | Interest Expense | (5,840) | 2,916 | 2,924 | 2,115 | | Income Before Tax | (3,601) | (4,615) | (8,873) | (15,620) | | Income Tax Expense | (120) | 1,076 | 1,096 | 1,147 | | Minority Interest |
-
|
-
|
-
| 81 | | | | Net Income From Continuing Ops | (3,154) | (5,691) | (9,969) | (16,686) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,154) | (5,691) | (9,969) | (16,686) | | Preferred Stock And Other Adjustments | (286) | 75 | 211 |
-
| | | Net Income Applicable To Common Shares | ($3,440) | ($5,616) | ($9,758) | ($16,686) |
|
0.02% Nasdaq 0.00%
Income Statement
